Covered recipient · General Payments record
JENNIFER A WEAVER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021–2024
$935.73
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $525.78 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $134.99 | 1 |
| BSN Medical Inc | $114.81 | 1 |
| Daiichi Sankyo Inc. | $101.43 | 4 |
| ABBVIE INC. | $43.44 | 2 |
| Pharmacosmos Therapeutics Inc. | $34.24 | 2 |
| Organon LLC | $24.40 | 1 |
| Astellas Pharma US Inc | $22.37 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $19.72 | 1 |
| Amgen Inc. | $16.11 | 1 |
| PFIZER INC. | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.31 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108387575 | CMS |
| ABBVIE INC. | $25.13 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108387577 | CMS |
| Alexion Pharmaceuticals, Inc. | $134.99 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093998538 | CMS |
| Amgen Inc. | $16.11 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116203153 | CMS |
| Astellas Pharma US Inc | $22.37 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139481016 | CMS |
| BSN Medical Inc | $114.81 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123333480 | CMS |
| Daiichi Sankyo Inc. | $23.16 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089496942 | CMS |
| Daiichi Sankyo Inc. | $19.64 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089496944 | CMS |
| Daiichi Sankyo Inc. | $29.20 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089496950 | CMS |
| Daiichi Sankyo Inc. | $29.43 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089496934 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $19.72 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154709457 | CMS |
| Organon Llc | $24.40 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136279463 | CMS |
| PFIZER INC. | $14.27 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131078255 | CMS |
| Pharmacosmos Therapeutics Inc. | $13.32 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154833300 | CMS |
| Pharmacosmos Therapeutics Inc. | $20.92 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154833302 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.